Loading...
Loading...
Contributors:
Dataset URI:
3f8be4cf-3016-403c-ad81-14a7b5fba750The purpose of this study is to evaluate whether overall survival for the trabectedin group is superior to the dacarbazine group for patients with advanced L-sarcoma (liposarcoma or leiomyosarcoma).
Keyword(s):
Advanced Liposarcoma or Leiomyosarcoma; Dacarbazine; Dexamethasone; Liposarcoma; Oncology.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)